Lenz & Staehelin advised Valartis in this transaction. Valartis AG (Valartis), a subsidiary of Valartis Group AG whose shares are listed on SIX Swiss Exchange, and...
Valartis AG’s Acquisition Of ENR Russia Invest SA
Venturi Partners’ $25 Million Investment in Dali Discount
Lenz & Staeeelin advised Venturi Partners on the deal. Venturi Partners, a prominent growth equity firm specialising in consumer investments across India and Southeast Asia, announced...
One Equity Partners’ Acquisition of Associated Spring and Hanggi From Barnes Group Inc.
Homburger advised One Equity Partners while Lenz & Staehelin advised Barnes Group Inc. on all Swiss related aspects of the transaction. Barnes Group Inc. (listed on...
PQ’s Acquisition of vanBaerle Group
Lenz & Staehelin advised PQ in this transaction. PQ, a global producer of silicates, silicas and derivate products and headquartered in the US, acquired the specialty...
Metall Zug’s Joint Venture With Miele
Lenz & Staehelin advises Metall Zug in this transaction. Metall Zug and Miele signed an agreement under which Metall Zug will contribute Belimed AG and Belimed...
Vencora UK Ltd’s Public Tender Offer For Shares of Crealogix Holding AG
Homburger AG advises Vencora and CSI while Lenz & Staehelin advised CREALOGIX in this transaction. Vencora UK Limited, an indirect subsidiary of Volaris Group Inc. and...
NewGAMe’s Partial Cash Tender Offer on GAM Holdin AG’ Shares
Lenz & Staehelin advises NewGAMe SA on its tender offer and continues to advise the investor group on its shareholding in GAM. NewGAMe SA announced the...
Hasten’s Acquisition of Commercial Rights for Rocephin from Roche
Lenz & Staehelin advised Hasten in this transaction. Hasten Biopharmaceutic Co., Ltd acquired the commercial rights in China for Rocephin®, a long-acting, broad spectrum cephalosporin antibiotic, from Swiss...